FDA chief Scott Gottlieb's resignation leaves 'billion-dollar question' for CBD industry

Indonesia Berita Berita

FDA chief Scott Gottlieb's resignation leaves 'billion-dollar question' for CBD industry
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 72%

Just a week ago, it looked like the Food and Drug Administration was ready to revisit its policies around CBD-infused food and drinks.

div > div.group > p:first-child"> While the federal government in December legalized CBD that's derived from hemp, a close cousin of marijuana, the FDA's rules still prohibit companies and restaurants from adding it to food or drinks. Cannabis start-ups, food companies and restaurants have pushed forward anyway, introducing CBD-infused seltzers and lattes in anticipation that the FDA would eventually tweak its rules.

Then on Tuesday, Gottlieb surprised executives with his announcement that he's stepping down in about a month, possibly before the hearing and certainly before any policy could be written and implemented.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

FDA Chief Scott Gottlieb to Leave AgencyFDA Chief Scott Gottlieb to Leave AgencyScott Gottlieb, the Food and Drug Administration commissioner who has presided over initiatives to limit the sale of e-cigarettes to children, is resigning.
Baca lebih lajut »

Biotech stocks fall after FDA chief Scott Gottlieb resignsBiotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Baca lebih lajut »

Trump FDA chief and vaping foe Scott Gottlieb resignsTrump FDA chief and vaping foe Scott Gottlieb resignsGottlieb, who'd fought against electronic cigarettes and opioid addiction, is reportedly leaving to spend more time with his family.
Baca lebih lajut »

FDA Chief Scott Gottlieb Has ResignedFDA Chief Scott Gottlieb Has ResignedThe FDA commissioner took stands against teen vaping and online opioid sales. His resignation letter did not explain why he was stepping down now.
Baca lebih lajut »

FDA chief Scott Gottlieb resigning, reports sayFDA chief Scott Gottlieb resigning, reports say
Baca lebih lajut »

FDA Commissioner Scott Gottlieb is resigningFDA Commissioner Scott Gottlieb is resigning
Baca lebih lajut »

Scott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDAScott Gottlieb, who won praise for trying to do his regulatory job, is quitting the FDAScott Gottlieb, possibly Trump's only effective regulator, announces his departure from the FDA — but what will come of his initiatives? hiltzikm weighs in:
Baca lebih lajut »

FDA Commissioner Scott Gottlieb resignsFDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb has resigned and plans to leave the agency in a month.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb to step downFDA Commissioner Scott Gottlieb to step downGottlieb noted his work to reduce tobacco use, discourage teen use of e-cigarettes, address the opioid epidemic and improve access to generic drugs.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorFDA Commissioner Scott Gottlieb just resigned as head of the US's top food and drug regulatorGottlieb worked in the healthcare industry before joining the Food and Drug Administration as its top official during the Trump administration.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb resignsFDA Commissioner Scott Gottlieb resignsFood and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency’s response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage vaping.
Baca lebih lajut »



Render Time: 2025-03-24 06:05:24